John P. Groten

4.2k total citations
87 papers, 3.1k citations indexed

About

John P. Groten is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Cancer Research. According to data from OpenAlex, John P. Groten has authored 87 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Health, Toxicology and Mutagenesis, 23 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in John P. Groten's work include Effects and risks of endocrine disrupting chemicals (20 papers), Carcinogens and Genotoxicity Assessment (18 papers) and Drug Transport and Resistance Mechanisms (13 papers). John P. Groten is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (20 papers), Carcinogens and Genotoxicity Assessment (18 papers) and Drug Transport and Resistance Mechanisms (13 papers). John P. Groten collaborates with scholars based in Netherlands, Germany and United Kingdom. John P. Groten's co-authors include V.J. Feron, Peter J. van Bladeren, Flemming R. Cassee, Rob Stierum, Ben van Ommen, Wilbert H. M. Heijne, Erwin Duizer, Jürgen Sühnel, Eric D. Schoen and Carolien Versantvoort and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and Environmental Health Perspectives.

In The Last Decade

John P. Groten

84 papers receiving 3.0k citations

Peers

Countries citing papers authored by John P. Groten

Since Specialization

Citations

This map shows the geographic impact of John P. Groten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Groten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Groten more than expected).

Fields of papers citing papers by John P. Groten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Groten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Groten. The network helps show where John P. Groten may publish in the future.

Co-authorship network of co-authors of John P. Groten

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Groten. A scholar is included among the top collaborators of John P. Groten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Groten. John P. Groten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The PKG Inhibitor CN238 Affords Functional Protection of Photoreceptors and Ganglion Cells against Retinal Degeneration 2023 ·International Journal of Molecular Sciences ·(unknown), Wadood Haq, (unknown), (unknown), (unknown), Andreas Rentsch, (unknown), Yu Zhu, John P. Groten, Frank Schwede, Tushar Tomar, Friedrich W. Herberg, Vasilica Nache, François Paquet‐Durand	6
2	Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue 2013 ·Toxicology in Vitro ·(unknown), (unknown), (unknown), Si Wang, W Roos, Andrea Romano, Laura H.J. de Haan, Albertinka J. Murk, A. Ederveen, Ivonne M.C.M. Rietjens, John P. Groten	7
3	Transcriptome analysis provides new insights into liver changes induced in the rat upon dietary administration of the food additives butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole 2008 ·Food and Chemical Toxicology ·Rob Stierum, Ana Conesa, Wilbert H. M. Heijne, Ben van Ommen, (unknown), Mary P. Scott, Roger J. Price, Clive Meredith, Brian G. Lake, John P. Groten	17
4	Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats 2008 ·Food and Chemical Toxicology ·Maaike E. Schutte, G.M. Alink, Andreas P. Freidig, Bert Spenkelink, (unknown), Johannes J.M. van de Sandt, John P. Groten, Ivonne M.C.M. Rietjens	6
5	Effects of flavonoid mixtures on the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers: An in vitro and kinetic modeling approach to predict the combined effects on transporter inhibition 2007 ·Food and Chemical Toxicology ·Maaike E. Schutte, Marelle G. Boersma, (unknown), John P. Groten, Ivonne M.C.M. Rietjens	12
6	Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients 2006 ·Biomedicine & Pharmacotherapy ·Walter Brand, Maaike E. Schutte, Gary Williamson, Jelmer J. van Zanden, Nicole H.P. Cnubben, John P. Groten, Peter J. van Bladeren, Ivonne M.C.M. Rietjens	121
7	Toxicogenomic analysis of gene expression changes in rat liver after a 28-day oral benzene exposure 2005 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Wilbert H. M. Heijne, (unknown), Rob Stierum, Ben van Ommen, John P. Groten	29
8	Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals 2005 ·Toxicology and Applied Pharmacology ·Rob Stierum, Wilbert H. M. Heijne, Anne S. Kienhuis, (unknown), John P. Groten	32
9	Bromobenzene-Induced Hepatotoxicity at the Transcriptome Level 2004 ·Toxicological Sciences ·Wilbert H. M. Heijne, Angela L. Slitt, Peter J. van Bladeren, John P. Groten, Curtis D. Klaassen, Rob Stierum, Ben van Ommen	68
10	Nutrigenomics in Efficacy and Safety Evaluation of Food Components 2004 ·World review of nutrition and dietetics ·Ben van Ommen, John P. Groten	3
11	Toxicology of chemical mixtures: a challenging quest along empirical sciences 2004 ·Environmental Toxicology and Pharmacology ·John P. Groten, Wilbert H. M. Heijne, Rob Stierum, Andreas P. Freidig, V.J. Feron	18
12	Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2 2003 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Rob Stierum, Marco Gaspari, Yvonne E.M. Dommels, Taoufik Ouatas, Helma Pluk, Sonja Jespersen, Jack Vogels, Kitty Verhoeckx, John P. Groten, Ben van Ommen	104
13	Statistically designed experiments in a tiered approach to screen mixtures of Fusarium mycotoxins for possible interactions 2002 ·Food and Chemical Toxicology ·O. Tajima, Eric D. Schoen, V.J. Feron, John P. Groten	66
14	In Vitro Intestinal Lead Uptake and Transport in Relation to Speciation 2002 ·Archives of Environmental Contamination and Toxicology ·Agnes G. Oomen, Johannes Tolls, Adriënne J.A.M. Sips, John P. Groten	49
15	International issues on human health effects of exposure to chemical mixtures. 2002 ·Environmental Health Perspectives ·V.J. Feron, Flemming R. Cassee, John P. Groten, (unknown), (unknown)	73
16	An Analysis of the Possibility for Health Implications of Joint Actions and Interactions between Food Additives 2000 ·Regulatory Toxicology and Pharmacology ·John P. Groten, W. H. Butler, V.J. Feron, G. Kozianowski, A.G. Renwick, Ron Walker	54
17	Toxicology of chemical mixtures: international perspective. 1998 ·Environmental Health Perspectives ·V.J. Feron, Flemming R. Cassee, John P. Groten	40
18	Comparative toxicity and accumulation of cadmium chloride and cadmium-metallothionein in primary cells and cell lines of rat intestine, liver and kidney 1992 ·Toxicology in Vitro ·John P. Groten, J. B. Luten, I.M. Bruggeman, J.H.M. Temmink, Peter J. van Bladeren	16
19	Reversible interaction of a reactive intermediate derived from furazolidone with glutathione and protein 1988 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), John P. Groten, J.H. Koeman, Peter J. van Bladeren	40
20	Identification of a reactive intermediate of furazolidone formed by swine liver microsomes 1987 ·Chemico-Biological Interactions ·(unknown), John P. Groten, (unknown), (unknown), Peter J. van Bladeren	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact